Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Lorundrostat hydrobromide by Mineralys Therapeutics for Hypertension: Likelihood of Approval
Lorundrostat hydrobromide is under clinical development by Mineralys Therapeutics and currently in Phase III for Hypertension. According to GlobalData, Phase...
Lorundrostat hydrobromide by Mineralys Therapeutics for Chronic Kidney Disease (Chronic Renal Failure): Likelihood of Approval
Lorundrostat hydrobromide is under clinical development by Mineralys Therapeutics and currently in Phase II for Chronic Kidney Disease (Chronic Renal...
Lorundrostat hydrobromide by Mineralys Therapeutics for Resistant Hypertension: Likelihood of Approval
Lorundrostat hydrobromide is under clinical development by Mineralys Therapeutics and currently in Phase III for Resistant Hypertension. According to GlobalData,...